Akèy › Ateroskleroz › Pennsylvania
Etid klinik pou Ateroskleroz nan Pennsylvania
11 etid pou Ateroskleroz ap chèche patisipan nan sit nan Pennsylvania.
Vil nan Pennsylvania
Tèks ofisyèl etid la (Anglè)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Suburban Research Associates, West Chester
- Cardiology Consultants of Philadelphia Yardley, Yardley
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Preferred Primary Care Physicians, Inc, Pittsburgh
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Lehigh Valley Health Network, Allentown
- Capital Area Research, LLC, Camp Hill
- Altoona Center For Clinical Research, Duncansville
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Capital Area Research, LLC - Camp Hill, Camp Hill
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07521007Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Heritage Valley Multispecialty Group Inc, Beaver
- Capital Area Research LLC, Camp Hill
- Abington Medical Specialists, Horsham
Ap rekriteFaz 3
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Heart and Vascular Research at WellSpan Health, York
Ap rekriteFaz 3
Laj 45 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07613294Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Northeast Clinical Research Center, LLC, Bethlehem
- Clinical Renal Associates, LTD, Exton
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Camp Hill
- Research Site, Horsham
- Research Site, Philadelphia
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357Pelacarsen Roll-over Extension Program
- Care Access Research, Easton
- TCV Clinical Studies, Linwood
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Jul 29, 2026 · NCT06875973MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
Ap rekriteFaz 3
Laj 35 a 89 · Tout sèks · Mizajou Apr 21, 2026 · NCT05132439How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses
- UPMC Montefiore - Clinical and Translational Research Center (CTRC), Pittsburgh
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Mar 25, 2026 · NCT07121010Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.